{"indexed":{"date-parts":[[2019,11,22]],"date-time":"2019-11-22T23:58:22Z","timestamp":1574467102017},"reference-count":38,"publisher":"Wiley","issue":"6","license":[{"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1","start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"delay-in-days":2147,"content-version":"tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"DOI":"10.1111\/j.1365-2265.2009.03728.x","type":"article-journal","created":{"date-parts":[[2009,10,15]],"date-time":"2009-10-15T08:09:51Z","timestamp":1255594191000},"page":"752-757","source":"Crossref","is-referenced-by-count":38,"title":"The effect of teriparatide on serum Dickkopf-1 levels in postmenopausal women with established osteoporosis","prefix":"10.1111","volume":"72","author":[{"given":"Athanasios D.","family":"Anastasilakis","sequence":"first","affiliation":[]},{"given":"Stergios A.","family":"Polyzos","sequence":"additional","affiliation":[]},{"given":"Avraam","family":"Avramidis","sequence":"additional","affiliation":[]},{"given":"Konstantinos A.","family":"Toulis","sequence":"additional","affiliation":[]},{"given":"Athanasios","family":"Papatheodorou","sequence":"additional","affiliation":[]},{"given":"Evangelos","family":"Terpos","sequence":"additional","affiliation":[]}],"member":"311","published-online":{"date-parts":[[2009,10,15]]},"reference":[{"key":"10.1111\/j.1365-2265.2009.03728.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1016\/S0140-6736(06)68891-0","article-title":"Osteoporosis","volume":"367","author":"Sambrook","year":"2006","journal-title":"Lancet"},{"key":"10.1111\/j.1365-2265.2009.03728.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/jcb.21840","article-title":"Oxysterol-induced osteogenic differentiation of marrow stromal cells is regulated by Dkk-1 inhibitable and PI3-kinase mediated signaling","volume":"105","author":"Amantea","year":"2008","journal-title":"Journal of Cellular Biochemistry"},{"key":"10.1111\/j.1365-2265.2009.03728.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1210\/er.2004-0006","article-title":"Parathyroid hormone and teriparatide for the treatment of osteoporosis: a review of the evidence and suggested guidelines for its use","volume":"26","author":"Hodsman","year":"2005","journal-title":"Endocrine Reviews"},{"key":"10.1111\/j.1365-2265.2009.03728.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"4528","DOI":"10.1210\/jc.2002-020334","article-title":"A randomized double-blind trial to compare the efficacy of teriparatide [recombinant human parathyroid hormone (1-34)] with alendronate in postmenopausal women with osteoporosis","volume":"87","author":"Body","year":"2002","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1111\/j.1365-2265.2009.03728.x-BIB5|cit5","first-page":"210","article-title":"Method for determination of bone alkaline phosphatase activity;analytical performance and clinical usefulness in patients with metabolic and malignant bone diseases","volume":"42","author":"Withold","year":"1996","journal-title":"Clinical Chemistry"},{"key":"10.1111\/j.1365-2265.2009.03728.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1056\/NEJM200105103441904","article-title":"Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis","volume":"344","author":"Neer","year":"2001","journal-title":"New England Journal of Medicine"},{"key":"10.1111\/j.1365-2265.2009.03728.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"3970","DOI":"10.1210\/jc.2003-1703","article-title":"Early changes in biochemical markers of bone formation correlate with improvements in bone structure during teriparatide therapy","volume":"90","author":"Dobnig","year":"2005","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1111\/j.1365-2265.2009.03728.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.bone.2006.02.003","article-title":"Fracture risk reduction during treatment with teriparatide is independent of pretreatment bone turnover","volume":"39","author":"Delmas","year":"2006","journal-title":"Bone"},{"key":"10.1111\/j.1365-2265.2009.03728.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1111\/j.1742-1241.2008.01768.x","article-title":"Head-to-head comparison of risedronate versus teriparatide on bone turnover markers in women with postmenopausal osteoporosis: a randomized trial","volume":"62","author":"Anastasilakis","year":"2008","journal-title":"International Journal of Clinical Practice"},{"key":"10.1111\/j.1365-2265.2009.03728.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1210\/er.2002-0023","article-title":"Bone morphogenetic proteins, their antagonists, and the skeleton","volume":"24","author":"Canalis","year":"2003","journal-title":"Endocrine Reviews"},{"key":"10.1111\/j.1365-2265.2009.03728.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1196\/annals.1334.010","article-title":"How Wnt signaling affects bone repair by mesenchymal stem cells from the bone marrow","volume":"1049","author":"Gregory","year":"2005","journal-title":"Annals of New York Academy Science"},{"key":"10.1111\/j.1365-2265.2009.03728.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1056\/NEJMra067395","article-title":"Mechanisms of anabolic therapies for osteoporosis","volume":"357","author":"Canalis","year":"2007","journal-title":"New England Journal of Medicine"},{"key":"10.1111\/j.1365-2265.2009.03728.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1359\/jbmr.2003.18.10.1842","article-title":"BMP-2 controls alkaline phosphatase expression and osteoblast mineralization by a Wnt autocrine loop","volume":"18","author":"Rawadi","year":"2003","journal-title":"Journal of Bone and Mineral Research"},{"key":"10.1111\/j.1365-2265.2009.03728.x-BIB14|cit14","first-page":"S368","article-title":"Beta-catenin signaling during osteoblast differentiation","volume":"16","author":"Sheikh","year":"2001","journal-title":"Journal of Bone and Mineral Research"},{"key":"10.1111\/j.1365-2265.2009.03728.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.bone.2007.12.006","article-title":"Dkk1-induced inhibition of Wnt signaling in osteoblast differentiation is an underlying mechanism of bone loss in multiple myeloma","volume":"42","author":"Qiang","year":"2008","journal-title":"Bone"},{"key":"10.1111\/j.1365-2265.2009.03728.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1359\/JBMR.050614","article-title":"Downregulation of Wnt signaling by increased expression of Dickkopf-1 and -2 is a prerequisite for late-stage osteoblast differentiation of KS483 cells","volume":"20","author":"Van Der Horst","year":"2005","journal-title":"Journal of Bone and Mineral Research"},{"key":"10.1111\/j.1365-2265.2009.03728.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/1476-4598-6-71","article-title":"Attenuation of WNT signaling by DKK-1 and -2 regulates BMP2-induced osteoblast differentiation and expression of OPG, RANKL and M-CSF","volume":"6","author":"Fujita","year":"2007","journal-title":"Molecular Cancer"},{"key":"10.1111\/j.1365-2265.2009.03728.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"3319","DOI":"10.1002\/art.22867","article-title":"Wnt signaling antagonists are potential prognostic biomarkers for the progression of radiographic hip osteoarthritis in elderly Caucasian women","volume":"56","author":"Lane","year":"2007","journal-title":"Arthritis Rheumatism"},{"key":"10.1111\/j.1365-2265.2009.03728.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1038\/sj.bjc.6604069","article-title":"A potential role for Dkk-1 in the pathogenesis of osteosarcoma predicts novel diagnostic and treatment strategies","volume":"97","author":"Lee","year":"2007","journal-title":"British Journal of Cancer"},{"key":"10.1111\/j.1365-2265.2009.03728.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1111\/j.1600-0609.2008.01065.x","article-title":"Serum concentrations of DKK-1 correlate with the extent of bone disease in patients with multiple myeloma","volume":"80","author":"Kaiser","year":"2008","journal-title":"European Journal of Haematology"},{"key":"10.1111\/j.1365-2265.2009.03728.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1038\/sj.bjc.6603959","article-title":"Increased Dickkopf-1 expression in breast cancer bone metastases","volume":"97","author":"Voorzanger-Rousselot","year":"2007","journal-title":"British Journal of Cancer"},{"key":"10.1111\/j.1365-2265.2009.03728.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1007\/s00223-009-9225-y","article-title":"Assessment of circulating dickkopf-1 with a new two-site immunoassay in healthy subjects and women with breast cancer and bone metastases","volume":"84","author":"Voorzanger-Rousselot","year":"2009","journal-title":"Calcified Tissue International"},{"key":"10.1111\/j.1365-2265.2009.03728.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"725","DOI":"10.3324\/haematol.2008.000893","article-title":"Serum Dickkopf-1 is increased and correlates with reduced bone mineral density in patients with thalassemia-induced osteoporosis. Reduction post-zoledronic acid administration","volume":"94","author":"Voskaridou","year":"2009","journal-title":"Haematologica"},{"key":"10.1111\/j.1365-2265.2009.03728.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1507\/endocrj.K07E-123","article-title":"Endogenous intact PTH is suppressed during teriparatide (rhPTH 1-34) administration in postmenopausal women with established osteoporosis","volume":"55","author":"Anastasilakis","year":"2008","journal-title":"Endocrine Journal"},{"key":"10.1111\/j.1365-2265.2009.03728.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1172\/JCI28551","article-title":"Regulation of bone mass by Wnt signaling","volume":"116","author":"Krishnan","year":"2006","journal-title":"Journal of Clinical Investigation"},{"key":"10.1111\/j.1365-2265.2009.03728.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/jcb.21626","article-title":"PTH\/cAMP\/PKA signaling facilitates canonical Wnt signaling via inactivation of glycogen synthase kinase-3beta in osteoblastic Saos-2 cells","volume":"104","author":"Suzuki","year":"2008","journal-title":"Journal of Cellular Biochemistry"},{"key":"10.1111\/j.1365-2265.2009.03728.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1210\/en.2007-0910","article-title":"Modulation of dickkopf-1 attenuates glucocorticoid induction of osteoblast apoptosis, adipocytic differentiation, and bone mass loss","volume":"149","author":"Wang","year":"2008","journal-title":"Endocrinology"},{"key":"10.1111\/j.1365-2265.2009.03728.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.bone.2006.09.004","article-title":"Knocking down dickkopf-1 alleviates estrogen deficiency induction of bone loss. A histomorphological study in ovariectomized rats","volume":"40","author":"Wang","year":"2007","journal-title":"Bone"},{"key":"10.1111\/j.1365-2265.2009.03728.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1038\/sj.leu.2404843","article-title":"The effect of novel anti-myeloma agents on bone metabolism of patients with multiple myeloma","volume":"21","author":"Terpos","year":"2007","journal-title":"Leukemia"},{"key":"10.1111\/j.1365-2265.2009.03728.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"160","DOI":"10.2353\/ajpath.2007.051276","article-title":"Lack of noggin expression by cancer cells is a determinant of the osteoblast response in bone metastases","volume":"170","author":"Schwaninger","year":"2007","journal-title":"American Journal of Pathology"},{"key":"10.1111\/j.1365-2265.2009.03728.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/S8756-3282(00)00410-5","article-title":"Effect of high doses of oral risedronate (20\u2003mg\/day) on serum parathyroid hormone levels and urinary collagen cross-link excretion in postmenopausal women with spinal osteoporosis","volume":"28","author":"Zegels","year":"2001","journal-title":"Bone"},{"key":"10.1111\/j.1365-2265.2009.03728.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.bone.2005.03.018","article-title":"SOST is a target gene for PTH in bone","volume":"37","author":"Keller","year":"2005","journal-title":"Bone"},{"key":"10.1111\/j.1365-2265.2009.03728.x-BIB33|cit33","doi-asserted-by":"crossref","first-page":"4577","DOI":"10.1210\/en.2005-0239","article-title":"Chronic elevation of parathyroid hormone in mice reduces expression of sclerostin by osteocytes: a novel mechanism for hormonal control of osteoblastogenesis","volume":"146","author":"Bellido","year":"2005","journal-title":"Endocrinology"},{"key":"10.1111\/j.1365-2265.2009.03728.x-BIB34|cit34","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1002\/jcp.20834","article-title":"Bone anabolic effects of parathyroid hormone are blunted by deletion of the Wnt antagonist secreted frizzled-related protein-1","volume":"210","author":"Bodine","year":"2007","journal-title":"Journal of Cellular Physiology"},{"key":"10.1111\/j.1365-2265.2009.03728.x-BIB35|cit35","doi-asserted-by":"crossref","first-page":"19723","DOI":"10.1074\/jbc.M212226200","article-title":"Gene expression profiles and transcription factors involved in parathyroid hormone signaling in osteoblasts revealed by microarray and bioinformatics","volume":"278","author":"Qin","year":"2003","journal-title":"Journal of Biological Chemistry"},{"key":"10.1111\/j.1365-2265.2009.03728.x-BIB36|cit36","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1359\/jbmr.061002","article-title":"Wnt but not BMP signaling is involved in the inhibitory action of sclerostin on BMP-stimulated bone formation","volume":"22","author":"Van Bezooijen","year":"2007","journal-title":"Journal of Bone and Mineral Research"},{"key":"10.1111\/j.1365-2265.2009.03728.x-BIB37|cit37","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1530\/EJE-07-0528","article-title":"Acute changes in serum osteoprotegerin and Receptor Activator for Nuclear Factor \u03baB ligand levels in women with established osteoporosis treated with teriparatide","volume":"158","author":"Anastasilakis","year":"2008","journal-title":"European Journal of Endocrinology"},{"key":"10.1111\/j.1365-2265.2009.03728.x-BIB38|cit38","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1093\/carcin\/bgm094","article-title":"The Wnt antagonist DICKKOPF-1 gene is induced by 1alpha,25-dihydroxyvitamin D3 associated to the differentiation of human colon cancer cells","volume":"28","author":"Aguilera","year":"2007","journal-title":"Carcinogenesis"}],"container-title":"Clinical Endocrinology","original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2265.2009.03728.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,24]],"date-time":"2019-02-24T02:45:08Z","timestamp":1550976308000},"score":1.0,"subtitle":["Teriparatide effect on serum Dickkopf-1"],"short-title":[],"issued":{"date-parts":[[2009,10,15]]},"references-count":38,"journal-issue":{"issue":"6"},"URL":"http:\/\/dx.doi.org\/10.1111\/j.1365-2265.2009.03728.x","relation":{"cites":[]},"ISSN":["0300-0664","1365-2265"],"subject":["Endocrinology, Diabetes and Metabolism"]}